The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Radiopharm Theranostics Ltd ADR’s current trading price is -89.18% away from its 52-week high, while its distance from the 52-week low is 54.93%. The stock’s price range for this period has been between $3.55 and $50.82 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 7.69 million for the day, a number notably higher than the average daily volume of 73560.0 over the last three months.
Analyzing Trading Volume and Moving Average Trends
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RADX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
RADX Stock Stochastic Average
As of today, Radiopharm Theranostics Ltd ADR’s raw stochastic average for the last 50 days stands at 26.17%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 21.88%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 36.15% and 46.34%, respectively.
RADX Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 22.49% since the start of this calendar year. Over the past 30 days, the price of RADX has fallen by 15.79%. And in the last five days, it has surged by 18.53%.
